Brief: HUTCHMED (China) Logs FY Net Income Attributable $456.9 Mln
05/03/2026 11:41
March 5 (Reuters) - HUTCHMED (China) Ltd 0013.HK: FY NET INCOME ATTRIBUTABLE $456.9 MILLION Further company coverage: 0013.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on HUTCHMED (China)
See all newsSovleplenib Granted FDA Orphan Drug Designation
Brief: Hutchmed (China) Says FDA Grants Orphan Drug Designation To Sovleplenib For Autoimmune Hemolytic Anemia
Regulatory Filings Accepted for Review
Brief: HUTCHMED (China) Says Regulatory Filings For Orpathys Plus Tagrisso Accepted For Review In Europe And Japan
US FDA Grants Sovleplenib Orphan Drug Designation